Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak-124001, Haryana, India.
Behav Brain Res. 2019 May 17;364:85-98. doi: 10.1016/j.bbr.2019.02.007. Epub 2019 Feb 6.
The present study was designed to investigate the effect of ascorbic acid (AA) treatment on the anxiety related behavioral and neurochemical alterations. AA (50, 100 and 200 mg/kg, i.p.) was administered to the mice and anxiety related behavior and levels of glutamate and nitrite in the brain of mice were determined. The results obtained revealed that the administration of AA (100 mg/kg, i.p.) significantly reduced the anxiety related behavior and the levels of nitrite in the brain of mice. Nitrergic interactions were further determined by the pretreatment of mice with nitric oxide (NO) modulator and AA treatment followed by behavioral and neurochemical measurements. The results obtained suggested that NO inhibition potentiated the anxiolytic like activity of AA in mice. It was also observed that the glutamate and nitrite level in the brain of mice were significantly reduced by the NO inhibitor pretreatment. Thus, the present study demonstrated the possible nitrergic pathways modulation in the anxiolytic like activity of AA in mice.
本研究旨在探讨抗坏血酸 (AA) 治疗对焦虑相关行为和神经化学改变的影响。将 AA(50、100 和 200mg/kg,腹腔注射)给予小鼠,并测定小鼠的焦虑相关行为和大脑中的谷氨酸和亚硝酸盐水平。结果表明,AA(100mg/kg,腹腔注射)给药可显著降低小鼠的焦虑相关行为和大脑中亚硝酸盐水平。通过用一氧化氮 (NO) 调节剂预处理小鼠和随后进行行为和神经化学测量,进一步确定了氮能相互作用。结果表明,NO 抑制增强了 AA 在小鼠中的抗焦虑样活性。还观察到,NO 抑制剂预处理可显著降低小鼠大脑中的谷氨酸和亚硝酸盐水平。因此,本研究表明 AA 的抗焦虑样活性可能涉及氮能途径的调节。